Skip to main content
. 2020 Apr 8;11(4):225. doi: 10.1038/s41419-020-2422-3

Fig. 7. Depletion of ZNF703 enhances the sensitivity of HCC cells to sorafenib treatment.

Fig. 7

A Overexpression of ZNF703 in SMMC7721 decreased their sensitivity to sorafenib treatment, whereas depletion of ZNF703 in HCCLM3 cells increased their sensitivity to sorafenib treatment, which be rescued by ZNF703 overexpression. B The influence of silencing ZNF703 or treatment with sorafenib on the effects of colony formation in HCCLM3 cell. C The HCCLM3-shZNF703 or corresponding control cells were subcutaneously inoculated into nude mice. After subcutaneous inoculation, mice were given sorafenib (2 mg/kg) per 2 days. Then, 4 weeks after giving sorafenib, mice were harvested and xerographs were collected. Comparison of tumor weights and tumor volumes for each groups (n = 6). D Expression of ZNF703, CLDN4 and Ki67 was evaluated by immunohistochemistry in xenografts derived from HCC cells. Scale bars: 75 μm. Data are presented as mean±S.D for three independent experiments. *P < 0.05.